DAVOS 2019: CREATING A STAGE
First-Ever Event dedicated to the Science of Psychedelics for Mental Health in Davos
Lampsai organised the first-ever event related to brain science & psychedelics on the Promenade in Davos during the World Economic Forum. Our goal was to add to the understanding of what creates anxiety, depression, addiction, and other challenges of the brain, and bring forward alternative healing modalities which target the source of these conditions, and heal them at root cause rather that only addressing the symptoms.
The panel discussion attracted great interest among the WEF participants and generated a long waiting list. The session led to significant rise in public awareness around the growing global mental health concerns illuminating both ‘why' and ’what’ of the subject.
DAVOS 2019: Panel Discussion
Christian Angermayer
Entrepreneur & Investor. Founder & CEO, Apeiron Investment Group
Khaliya
MPH, Health Futurist and Co-founder, Falkora
James Hewitt
Head of Science & Innovation at Hintsa Performance and an Active Researcher at Loughborough University
Prof. Olivier Oullier
Neuroscientist. Professor of Behavioral and Brain Sciences at Aix-Marseille University
Lars Christian Wilde
President, Chief Business Officer, and Co-Founder of COMPASS Pathways